Literature DB >> 21527752

Atheroprotective reverse cholesterol transport pathway is defective in familial hypercholesterolemia.

Natacha Bellanger1, Alexina Orsoni, Zélie Julia, Natalie Fournier, Eric Frisdal, Emilie Duchene, Eric Bruckert, Alain Carrie, Dominique Bonnefont-Rousselot, John Pirault, Flora Saint-Charles, M John Chapman, Philippe Lesnik, Wilfried Le Goff, Maryse Guerin.   

Abstract

OBJECTIVE: Low high-density lipoprotein (HDL) cholesterol levels are frequently observed in familial hypercholesterolemia (FH) and might be associated with functional alterations of HDL particles that may influence their efficaciousness in the reverse cholesterol transport pathway. METHODS AND
RESULTS: We evaluated key steps of the reverse cholesterol transport, ie, cellular free cholesterol efflux, cholesteryl ester transfer protein-mediated cholesteryl ester (CE) transfer from HDL to apolipoprotein B-containing lipoproteins, and hepatic HDL-CE uptake, in patients displaying FH (n = 12) and in healthy normolipidemic control subjects (n = 12). Large HDL2 particles isolated from FH patients displayed a reduced capacity to mediate free cholesterol efflux via both scavenger receptor-BI- and ABCG1-dependent pathways. A significant inverse relationship between scavenger receptor-BI-dependent HDL2 efflux capacity and carotid intima-media thickness (r = -0.473; P = 0.0186), as well as between ABCG1-dependent HDL2 efflux capacity and carotid intima-media thickness (r = -0.485; P = 0.0212), was detected. We also observed an elevated cholesteryl ester transfer protein-mediated CE transfer from HDL2 and HDL3 particles to low-density lipoprotein and a reduced capacity of HDL particles to deliver CEs to the liver.
CONCLUSIONS: We demonstrated that the centripetal movement of cholesterol from peripheral tissues, including the vessel wall, to feces is defective in FH, thereby emphasizing its atherogenicity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21527752     DOI: 10.1161/ATVBAHA.111.227181

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

1.  LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection.

Authors:  Alexina Orsoni; Samir Saheb; Johannes H M Levels; Geesje Dallinga-Thie; Marielle Atassi; Randa Bittar; Paul Robillard; Eric Bruckert; Anatol Kontush; Alain Carrié; M John Chapman
Journal:  J Lipid Res       Date:  2011-09-26       Impact factor: 5.922

2.  High-Density Lipoprotein (HDL) Phospholipid Content and Cholesterol Efflux Capacity Are Reduced in Patients With Very High HDL Cholesterol and Coronary Disease.

Authors:  Anandita P Agarwala; Amrith Rodrigues; Marjorie Risman; Mary McCoy; Kevin Trindade; Liming Qu; Marina Cuchel; Jeffrey Billheimer; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-04-02       Impact factor: 8.311

Review 3.  Clinical and biological relevance of statin-mediated changes in HDL metabolism.

Authors:  Benoit J Arsenault; S Matthijs Boekholdt
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

Review 4.  Recommendations for the management of patients with familial hypercholesterolemia.

Authors:  David I Feldman; Michael J Blaha; Raul D Santos; Steve R Jones; Roger S Blumenthal; Peter P Toth; Laurence S Sperling; Seth S Martin
Journal:  Curr Atheroscler Rep       Date:  2015-01       Impact factor: 5.113

Review 5.  Reverse Cholesterol Transport Dysfunction Is a Feature of Familial Hypercholesterolemia.

Authors:  Joan Carles Escolà-Gil; Noemí Rotllan; Josep Julve; Francisco Blanco-Vaca
Journal:  Curr Atheroscler Rep       Date:  2021-04-29       Impact factor: 5.113

6.  Impact of LDL apheresis on atheroprotective reverse cholesterol transport pathway in familial hypercholesterolemia.

Authors:  Alexina Orsoni; Elise F Villard; Eric Bruckert; Paul Robillard; Alain Carrie; Dominique Bonnefont-Rousselot; M John Chapman; Geesje M Dallinga-Thie; Wilfried Le Goff; Maryse Guerin
Journal:  J Lipid Res       Date:  2012-02-15       Impact factor: 5.922

7.  Cellular cholesterol efflux and cholesterol loading capacity of serum: effects of LDL-apheresis.

Authors:  M P Adorni; F Zimetti; M Puntoni; F Bigazzi; F Sbrana; F Minichilli; F Bernini; N Ronda; E Favari; T Sampietro
Journal:  J Lipid Res       Date:  2012-03-12       Impact factor: 5.922

8.  ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.

Authors:  Judit Cubedo; Teresa Padró; Rodrigo Alonso; Pedro Mata; Lina Badimon
Journal:  J Lipid Res       Date:  2016-04-25       Impact factor: 5.922

9.  An analysis of the risk factors for premature coronary artery disease in young and middle-age Chinese patients with hypertension.

Authors:  Jingjin Che; Guangping Li; Yuanxia Shao; Haifang Niu; Yanli Shi
Journal:  Exp Clin Cardiol       Date:  2013

Review 10.  Molecular mechanisms of vascular effects of High-density lipoprotein: alterations in cardiovascular disease.

Authors:  Christian Besler; Thomas F Lüscher; Ulf Landmesser
Journal:  EMBO Mol Med       Date:  2012-03-16       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.